This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Chemical Company, Limited. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: Shigeharu Ueda: Innovator in H.I.V. Treatment
Introduction
Shigeharu Ueda is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of medical treatment, particularly in the area of H.I.V. His innovative approach has the potential to improve the lives of many individuals affected by this disease.
Latest Patents
Ueda holds a patent for a method of treating acquired immuno-deficiency syndrome (AIDS). This patent, which is focused on utilizing specific inhibition of protein synthesis, involves administering a therapeutically effective amount of liposomes containing a toxin that specifically inhibits protein synthesis in cells to patients with AIDS. This groundbreaking method showcases Ueda's commitment to advancing medical science.
Career Highlights
Shigeharu Ueda is associated with Sumitomo Chemical Company, Limited, where he has been able to apply his expertise in developing innovative treatments. His work has garnered attention for its potential impact on public health and the treatment of H.I.V.
Collaborations
Ueda has collaborated with notable colleagues, including Kazuyoshi Ikuta and Shiro Kato. These partnerships have allowed for the exchange of ideas and expertise, further enhancing the development of effective treatments.
Conclusion
Shigeharu Ueda's contributions to H.I.V. treatment through his innovative patent reflect his dedication to improving healthcare. His work continues to inspire advancements in medical research and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile